PortfoliosLab logoPortfoliosLab logo
GLMD vs. IAK
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GLMD vs. IAK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Galmed Pharmaceuticals Ltd. (GLMD) and iShares U.S. Insurance ETF (IAK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GLMD achieves a -17.26% return, which is significantly lower than IAK's 10.07% return. Over the past 10 years, GLMD has underperformed IAK with an annualized return of -50.77%, while IAK has yielded a comparatively higher 13.45% annualized return.


GLMD

1D
3.67%
1M
8.87%
6M
-12.54%
YTD
-17.26%
1Y
-59.94%
3Y*
-63.68%
5Y*
-73.19%
10Y*
-50.77%
ALL TIME*
-49.67%

IAK

1D
-0.31%
1M
-0.06%
6M
12.67%
YTD
10.07%
1Y
19.63%
3Y*
19.72%
5Y*
15.95%
10Y*
13.45%
ALL TIME*
7.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$238.83K$503.27K$408.11K
$14.76M$20.90M$11.89M

GLMD vs. IAK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GLMD
Galmed Pharmaceuticals Ltd.
-17.26%-76.47%-41.58%-93.93%-72.53%-41.48%-46.19%-15.37%-25.36%160.68%
IAK
iShares U.S. Insurance ETF
10.07%9.50%28.25%11.28%11.33%26.84%-2.86%25.94%-11.48%14.18%

Correlation

The correlation between GLMD and IAK is -0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.04

Correlation (3Y)
Balances recent behavior with more history.

-0.03

Correlation (5Y)
Shows whether the relationship held over a longer period.

-0.01

Correlation (10Y)
Provides a long-term view across more market conditions.

0.07

Correlation (All Time)
Calculated using the full available price history since Mar 13, 2014

0.09

The correlation between GLMD and IAK shifts across timeframes, from -0.04 (1 year) to 0.09 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GLMD vs. IAK — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

GLMD
GLMD Risk / Return Rank: 1414
Overall Rank
GLMD Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
GLMD Sortino Ratio Rank: 1515
Sortino Ratio Rank
GLMD Omega Ratio Rank: 1616
Omega Ratio Rank
GLMD Calmar Ratio Rank: 99
Calmar Ratio Rank
GLMD Martin Ratio Rank: 1313
Martin Ratio Rank

IAK
IAK Risk / Return Rank: 5353
Overall Rank
IAK Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
IAK Sortino Ratio Rank: 4848
Sortino Ratio Rank
IAK Omega Ratio Rank: 4545
Omega Ratio Rank
IAK Calmar Ratio Rank: 7171
Calmar Ratio Rank
IAK Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

GLMD vs. IAK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and iShares U.S. Insurance ETF (IAK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GLMDIAKDifference
Sharpe ratioReturn per unit of total volatility

-1.84

Sortino ratioReturn per unit of downside risk

-2.55

Omega ratioGain probability vs. loss probability

0.90

1.21

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.87

2.45

-3.32

Martin ratioReturn relative to average drawdown

-1.25

5.96

-7.21

GLMD vs. IAK - Sharpe Ratio Comparison

The current GLMD Sharpe Ratio is -0.68, which is lower than the IAK Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of GLMD and IAK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GLMD vs. IAK - Drawdown Comparison

The maximum GLMD drawdown since its inception was -99.99%, which is greater than IAK's maximum drawdown of -77.38%. Use the drawdown chart below to compare losses from any high point for GLMD and IAK.


Loading charts...

Drawdown Indicators


GLMDIAKDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-77.38%

-22.61%

Max Drawdown (1Y)

Largest decline over 1 year

-71.21%

-7.62%

-63.59%

Max Drawdown (3Y)

Largest decline over 3 years

-96.89%

-11.58%

-85.31%

Max Drawdown (5Y)

Largest decline over 5 years

-99.92%

-14.76%

-85.16%

Max Drawdown (10Y)

Largest decline over 10 years

-99.99%

-44.95%

-55.04%

Current Drawdown

Current decline from peak

-99.98%

-3.23%

-96.75%

Average Drawdown

Average peak-to-trough decline

-76.28%

-16.01%

-60.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

49.60%

3.13%

+46.47%

Volatility

GLMD vs. IAK - Volatility Comparison

Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 23.75% compared to iShares U.S. Insurance ETF (IAK) at 7.03%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than IAK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GLMDIAKDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.75%

7.03%

+16.72%

Volatility (6M)

Calculated over the trailing 6-month period

76.21%

12.43%

+63.78%

Volatility (1Y)

Calculated over the trailing 1-year period

91.92%

16.00%

+75.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

166.97%

18.13%

+148.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

138.32%

20.92%

+117.40%

Dividends

GLMD vs. IAK - Dividend Comparison

GLMD has not paid dividends to shareholders, while IAK's dividend yield for the trailing twelve months is around 2.43%.


PositionTTM20252024202320222021202020192018201720162015
GLMD
Galmed Pharmaceuticals Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IAK
iShares U.S. Insurance ETF
2.43%1.69%1.49%1.44%1.69%2.26%2.07%1.84%2.33%1.62%1.68%1.62%

Frequently Asked Questions


GLMD and IAK have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GLMD has higher volatility (23.75%) compared to IAK (7.03%). In terms of maximum drawdown, GLMD dropped -99.99% vs IAK's -77.38%.

IAK currently has the higher Sharpe Ratio (1.17 vs -0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GLMD and IAK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer